Skip to content
10-Q

Quarterly Report

Deciphera Pharmaceuticals, Inc.

0001654151-23-000015

← back to feed
Filed
Aug 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Jul 28, 2023 78.82M sh
Shares Diluted Q2 2023 · Jun 30, 2023 85.02M sh
Shares Diluted Q2 2023 · Jun 30, 2023 83.85M sh
Shares Diluted Q2 2023 · Jun 30, 2022 72.13M sh
Shares Diluted Q2 2023 · Jun 30, 2022 68.44M sh
Capex Q2 2023 · Jun 30, 2023 $653K
Capex Q2 2023 · Jun 30, 2022 $287K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$88.08M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$96.88M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $81.39M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $64.74M
Stockholders Equity Q2 2023 · Jun 30, 2023 $404.43M
Stockholders Equity Q2 2023 · Mar 31, 2023 $440.08M
Stockholders Equity Q2 2023 · Dec 31, 2022 $341.69M
Stockholders Equity Q2 2023 · Jun 30, 2022 $405.01M
Stockholders Equity Q2 2023 · Mar 31, 2022 $271.57M
Stockholders Equity Q2 2023 · Dec 31, 2021 $304.72M
Current Liabilities Q2 2023 · Jun 30, 2023 $81.03M
Current Liabilities Q2 2023 · Dec 31, 2022 $86.47M
Total Liabilities Q2 2023 · Jun 30, 2023 $105.19M
Total Liabilities Q2 2023 · Dec 31, 2022 $112.35M
Current Assets Q2 2023 · Jun 30, 2023 $405.05M
Current Assets Q2 2023 · Dec 31, 2022 $392.96M
Total Assets Q2 2023 · Jun 30, 2023 $509.62M
Total Assets Q2 2023 · Dec 31, 2022 $454.04M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.57
Eps Diluted Q2 2023 · Jun 30, 2023 −$1.17
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.60
Eps Diluted Q2 2023 · Jun 30, 2022 −$1.31
Eps Basic Q2 2023 · Jun 30, 2023 −$0.57
Eps Basic Q2 2023 · Jun 30, 2023 −$1.17
Eps Basic Q2 2023 · Jun 30, 2022 −$0.60
Eps Basic Q2 2023 · Jun 30, 2022 −$1.31
Sga Expense Q2 2023 · Jun 30, 2023 $32.61M
Sga Expense Q2 2023 · Jun 30, 2023 $64.06M
Sga Expense Q2 2023 · Jun 30, 2022 $29.63M
Sga Expense Q2 2023 · Jun 30, 2022 $57.95M
Rd Expense Q2 2023 · Jun 30, 2023 $58.3M
Rd Expense Q2 2023 · Jun 30, 2023 $113.06M
Rd Expense Q2 2023 · Jun 30, 2022 $44.86M
Rd Expense Q2 2023 · Jun 30, 2022 $92.27M
Net Income Q2 2023 · Jun 30, 2023 −$48.56M
Net Income Q2 2023 · Jun 30, 2023 −$98.17M
Net Income Q2 2023 · Dec 31, 2022 −$178.9M
Net Income Q2 2023 · Jun 30, 2022 −$43.06M
Net Income Q2 2023 · Jun 30, 2022 −$89.95M
Operating Income Q2 2023 · Jun 30, 2023 −$52.78M
Operating Income Q2 2023 · Jun 30, 2023 −$106.03M
Operating Income Q2 2023 · Jun 30, 2022 −$43.79M
Operating Income Q2 2023 · Jun 30, 2022 −$90.68M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $173K
Cost Of Revenue Q2 2023 · Jun 30, 2023 $661K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $1.8M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $2.18M
Revenue Q2 2023 · Jun 30, 2023 $38.3M
Revenue Q2 2023 · Jun 30, 2023 $71.75M
Revenue Q2 2023 · Jun 30, 2022 $32.49M
Revenue Q2 2023 · Jun 30, 2022 $61.72M